Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Stomach Neoplasms × Hepatectomy × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 14 Recurrence 3 Cholangiocarcinoma 2 Stomach Neoplasms 1 Reperfusion Injury 1 Postoperative Complications 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Liver Neoplasms 1 Klatskin Tumor 1 Hypertension, Portal 1 Disease Progression 1 Colorectal Neoplasms 1 Cirrhosis, Familial, with Pulmonary Hypertension 1

Interventions

Oxaliplatin 73 S 1 (combination) 50 Capecitabine 38 apatinib 31 Paclitaxel 30 Docetaxel 29 Irinotecan 26 Drug Therapy 22 Fluorouracil 19 sintilimab 17 Cisplatin 15 Leucovorin 14 XELOX 11 Surgical Procedures, Operative 11 Hyperthermic Intraperitoneal Chemotherapy 11 camrelizumab 9 Trastuzumab 8 Tegafur 8 Nivolumab 8 Neoadjuvant Therapy 8 Laparoscopy 8 toripalimab 7 Ramucirumab 7 Gastrectomy 7 Chemotherapy, Adjuvant 7 titanium silicide 6 Gastroscopy 6 tislelizumab 5 pembrolizumab 5 gimeracil 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04574245 2022-10-05

RECORD

Chinese PLA General Hospital

Gastrointestinal

Neoplasm Metastasis, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡